The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
LINK TO FULL STUDY: https://pubmed.ncbi.nlm.nih.gov/34841223/
The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
LINK TO FULL STUDY: https://pubmed.ncbi.nlm.nih.gov/34841223/